Multicenter evaluation of the addition of eltrombopag to immunosuppressive therapy for adults with severe aplastic anemia

[1]  Xingmin Feng,et al.  Predicting response of severe aplastic anemia to immunosuppression combined with eltrombopag , 2021, Haematologica.

[2]  M. Wlodarski,et al.  Eltrombopag in children with severe aplastic anemia , 2021, Pediatric blood & cancer.

[3]  R. Wu,et al.  Efficacy and safety of eltrombopag in the first-line therapy of severe aplastic anemia in children , 2021, Pediatric hematology and oncology.

[4]  Sisi Li,et al.  Efficacy and safety of immunosuppressive therapy with or without eltrombopag in pediatric patients with acquired aplastic anemia: A Chinese retrospective study , 2021, Pediatric hematology and oncology.

[5]  N. Young,et al.  Eltrombopag added to immunosuppression for children with treatment‐naïve severe aplastic anaemia , 2021, British journal of haematology.

[6]  A. Matsuda,et al.  Eltrombopag in Combination with Rabbit Anti-thymocyte Globulin/Cyclosporine A in Immunosuppressive Therapy-naïve Patients with Aplastic Anemia in Japan , 2020, Internal medicine.

[7]  C. Lengerke,et al.  Pathogenesis of Acquired Aplastic Anemia and the Role of the Bone Marrow Microenvironment , 2018, Front. Oncol..

[8]  Z. Estrov,et al.  Addition of eltrombopag to immunosuppressive therapy in patients with newly diagnosed aplastic anemia , 2018, Cancer.

[9]  Y. Kwong,et al.  Eltrombopag in the management of aplastic anaemia: real-world experience in a non-trial setting , 2018, Hematology.

[10]  S. Parmar,et al.  Clinical outcomes in adult patients with aplastic anemia: A single institution experience , 2017, American journal of hematology.

[11]  T. Olson,et al.  Diagnosis and Treatment of Aplastic Anemia , 2017, Current Treatment Options in Oncology.

[12]  B. Dumitriu,et al.  Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia , 2017, The New England journal of medicine.

[13]  A. Bacigalupo.  How I treat acquired aplastic anemia. , 2017, Blood.

[14]  Inderjeet Dokal,et al.  Guidelines for the diagnosis and management of adult aplastic anaemia , 2016, British journal of haematology.

[15]  Z. Estrov,et al.  Single-Center Experience of Immunosuppressive Therapy with or without Eltrombopag in Patients with Aplastic Anemia , 2015 .

[16]  B. Grubeck‐Loebenstein,et al.  The aging bone marrow and its impact on immune responses in old age. , 2014, Immunology letters.

[17]  E. Thiel,et al.  A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA Working Party of the European Group for Blood and Marrow Transplantation. , 2011, Blood.

[18]  N. Young,et al.  Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized study , 2009, Haematologica.

[19]  M. Minden,et al.  Outcomes of older patients (≥60 years) with acquired aplastic anaemia treated with immunosuppressive therapy , 2008, British journal of haematology.

[20]  高橋 聡,et al.  Common Terminology Criteria for Adverse Events (CTCAE) v3.0による胃癌術後合併症の解析 , 2006 .

[21]  D. Follmann,et al.  Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. , 2003, JAMA.

[22]  H. Heimpel,et al.  Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia. , 2003, Blood.

[23]  Hauptadministrator,et al.  PACKAGE INSERT , 2004 .

[24]  Kensuke Usuki.  Aplastic Anemia , 1979, Haematology and Blood Transfusion / Hämatologie und Bluttransfusion.